News for JUBILANT PHARMOVA LTD (JUBLPHARMA.BO)

Indian markets closed slightly lower as gains in financial and oil & gas stocks were offset by consumer sector declines. Investors remained cautious ahead of the RBI policy meeting, with expectations of a rate cut driving interest in rate-sensitive sectors.

Stocks including Reliance Industries, Infosys, LTIMindtree, TCS, Axis Bank, BPCL, Havells, PFC, Mastek, TVS Motor, Mobikwik and more will be in the spotlight on Friday, January 17.

Indian benchmark indices recorded their worst session in over a month, pressured by uncertainty surrounding the US presidential election. The Nifty declined 1.27% to 23,995, and the Sensex dropped 1.18% to 78,782. Analysts suggest that the Nifty might extend its correction towards 23,650, while a decisive move above 24,100 could trigger a rally.

Indian benchmark equity indices gained during a special one-hour "muhurat" trading session on Friday, marking the Diwali festival, driven by auto stocks boosted by positive monthly sales data.

As many as 97 stocks hit their 52-week high levels today. BSE 500 stocks such as Crisil, Fortis Healthcare, Jubilant Pharmova, Poly Medicure, Piramal Pharma, and Suven Pharmaceuticals hit their respective one-year high levels.

Stocks including ITC, IndusInd Bank, NTPC, Axis Bank, IEX, Godrej CP, Coal India, Bharat Electronics, LTTS and more will be the spotlight on Friday, October 25.

Nuvama Insitutional Equities initiated coverage on Jubilant Pharmova Ltd. with a 'buy' rating and estimated the stock price to gain over 30%. The brokerage has a target price of Rs 1,450 per share, implying a 30.40% upside from Friday's closing price. Jubilant Pharmova is embarking on a new earning cycle with several growth factors at play, said Nuvama Insitutional Equities in a note on Monday.

Indian equity indices Sensex and Nifty50 registered their steepest drop in two months due to profit booking and weak Asian markets, breaking below key support levels. Analysts highlight potential further weakness with key support at 25,750 and resistance at 26,000. The bearish sentiment affected both major and smaller stocks.

Stocks including Manba Finance, Dr Reddy's, Adani Enterprises, Zomato, Bharat Electronics, Tata Motors, ICICI Pru Life, LTIMindTree and more will be the spotlight on Thursday, September 26.

Shares of Jubilant Pharmova surged 12 per cent on the BSE in Friday's intra-day trade to hit a new high of Rs 1,169.55, in an otherwise subdued market.

Drugmaker Jubilant Pharmova Ltd. announced on Tuesday that the manufacturing facility of its arm, Jubilant HollisterStier, based in Washington, has received 'voluntary action indicated' from the US Food and Drug Administration.

Domestic equity indices rose on Monday, with the Nifty 50 up 0.34% to 24,936 and the S&P BSE Sensex gaining 0.46% to 81,559. Analysts suggest resistance at 25,000-25,100 and support at 24,800-24,785, with a potential trend reversal if lower support levels are breached.

Indian equity markets ended flat on Tuesday. Analysts noted that profit-taking at highs and technical indicators suggest the Nifty could face resistance at 25,200-25,250, with support at 24,960-24,855. The market remains range-bound, with potential for a slight dip or rise depending on movements around 25,000 and 25,100.

BASF India, Linde India, Adani Green Energy and Jindal SAW witnessed 20-22 per cent jump in their FY25 EPS forecasts. Among them, BASF India and Jindal SAW also saw their FY26 estimates rising by 28 per cent and 18 per cent, respectively.

Indian equity indices ended Monday with mixed results. Gain in energy and metals stocks balanced by profit booking in financials left the Nifty 50 index slightly up and Sensex nearly unchanged. Analysts forecasted range-bound movement, noting crucial support and resistance levels.

Stocks including Reliance Industries, Adani Enterprises, GMR Airports, Mphasis, Hindustan Zinc and more may remain under the spotlight before the opening bell on Monday, August 19.

Companies including Tata Motors, ITC, Zomato, Maruti Suzuki, Adani Enterprises, Titan, AB Capital and more may remain under the spotlight before the opening bell on Friday, August 2.

Q1 earnings cheer: Lupin, Zydus Lifesciences, Glenmark Pharmaceuticals, Aurobindo Pharma, Torrent Pharmaceuticals and Sun Pharmaceutical were up between 2 per cent and 3 per cent.

Companies including ICICI Bank, BHEL, UltraTech, PNB, Dr Reddy's, InterGlobe, IDFC First Bank, Hindustan Zinc more may remain under the spotlight before the opening bell on Monday, July 29.